[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"biomarker:tnfrsf11a-wt-allele":3},{"name":4,"total":5,"recruiting":6,"trials":7},"TNFRSF11A wt Allele",13,8,[8,16,22,29,35,41,47,53,59,66,72,79,85],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT07456033","A Study of Efficacy and Safety of Depemokimab Compared With Placebo in Adults and Adolescents With at Risk Type 2 Asthma",[12],"Phase 3","RECRUITING","2026-08-26T02:16:59.895916Z","2026-07-05T03:45:20.255357Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":20,"content_modified":21},"NCT06979323","Depemokimab Asthma Imaging and Bronchoscopy Sub-Study",[12],"2026-08-26T02:18:25.327036Z","2026-05-05T02:43:29.588575Z",{"nct_id":23,"title":24,"phases":25,"status":13,"updated_at":27,"content_modified":28},"NCT06372249","A Clinical Trial of Soluble Fiber for Asthma",[26],"Phase 2","2026-08-26T02:17:26.640202Z","2026-05-05T02:43:28.121144Z",{"nct_id":30,"title":31,"phases":32,"status":13,"updated_at":33,"content_modified":34},"NCT03885245","Supplementing L-citrulline to Overweight Late Asthma oNset Phenotypes",[26],"2026-08-26T02:17:09.131534Z","2026-05-05T02:43:28.074040Z",{"nct_id":36,"title":37,"phases":38,"status":13,"updated_at":39,"content_modified":40},"NCT07323654","A Study of KT-621 Administered Orally to Adult Participants With Moderate to Severe Eosinophilic Asthma",[26],"2026-08-26T02:16:14.341106Z","2026-05-05T02:43:27.640751Z",{"nct_id":42,"title":43,"phases":44,"status":13,"updated_at":27,"content_modified":46},"NCT04743791","Measuring the Effect of Dupilumab Treatment on Mucociliary Clearance (MCC) in Subjects With Moderate to Severe Asthma",[45],"Phase 4","2026-05-05T02:43:26.738099Z",{"nct_id":48,"title":49,"phases":50,"status":13,"updated_at":51,"content_modified":52},"NCT04380038","Viral Infection in Asthma (VIA) Study",[45],"2026-08-26T02:15:57.572488Z","2026-05-05T02:35:31.898096Z",{"nct_id":54,"title":55,"phases":56,"status":13,"updated_at":57,"content_modified":58},"NCT06932263","Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids",[26],"2026-08-26T02:18:29.369233Z","2026-04-29T02:57:57.117985Z",{"nct_id":60,"title":61,"phases":62,"status":63,"updated_at":64,"content_modified":65},"NCT07705737","Rademikibart IV for Acute Asthma and COPD Exacerbation",[26],"NOT_YET_RECRUITING","2026-08-26T02:17:58.890423Z","2026-07-19T19:36:05.093788Z",{"nct_id":67,"title":68,"phases":69,"status":63,"updated_at":70,"content_modified":71},"NCT07675044","Quantifying the Burden of Type 2 (T2) Inflammation in Asthma",[],"2026-08-26T02:15:50.539717Z","2026-07-05T03:45:20.439160Z",{"nct_id":73,"title":74,"phases":75,"status":76,"updated_at":77,"content_modified":78},"NCT06940141","Rademikibart Add-on Treatment of an Acute Asthma Exacerbation (Seabreeze STAT Asthma)",[26],"ACTIVE_NOT_RECRUITING","2026-08-03T02:16:50.832618Z","2026-06-16T05:54:07.929293Z",{"nct_id":80,"title":81,"phases":82,"status":76,"updated_at":83,"content_modified":84},"NCT06940154","Rademikibart Add-on Treatment of an Acute COPD Exacerbation (Seabreeze STAT COPD)",[26],"2026-08-03T03:06:01.435370Z","2026-06-16T05:54:07.928811Z",{"nct_id":86,"title":87,"phases":88,"status":76,"updated_at":90,"content_modified":91},"NCT06637371","A Phase 1, Randomized, Double-blind, Placebo-controlled Study Evaluating AMG 691 in Healthy Participants and Participants With Mild-to-Moderate Asthma",[89],"Phase 1","2026-08-03T02:09:46.172607Z","2026-05-05T02:43:28.899265Z"]